Sernia, Conrad and Brown, Lindsay (2011) Emerging benefits of AT1 receptor antagonists with pleiotropic anti-inflammatory activity. American Journal of Hypertension, 24 (7). p. 739. ISSN 0895-7061
|HTML Citation||EndNote||Dublin Core||Reference Manager|
Full text not available from this archive.
Identification Number or DOI: doi: 10.1038/ajh.2011.61
In summary, angiotensin receptor antagonists with pleiotropic properties, such as telmisartan, have a great deal to recommend them in the treatment of the metabolic syndrome: they are antihypertensive, anti-inflammatory, may lower blood glucose concentrations, and normalize lipid homeostasis.
|Item Type:||Article (Commonwealth Reporting Category C)|
|Additional Information:||Permanent restricted access to published version due to publisher copyright policy. Note this is a C4 publication.|
|Uncontrolled Keywords:||metabolic syndrome; angiotensin receptor antagonists|
|Fields of Research (FOR2008):||11 Medical and Health Sciences > 1103 Clinical Sciences > 110306 Endocrinology|
11 Medical and Health Sciences > 1101 Medical Biochemistry and Metabolomics > 110107 Metabolic Medicine
06 Biological Sciences > 0606 Physiology > 060699 Physiology not elsewhere classified
|Socio-Economic Objective (SEO2008):||C Society > 92 Health > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920104 Diabetes|
|Deposited On:||08 Feb 2012 16:33|
|Last Modified:||23 Apr 2012 15:23|
Archive Staff Only: edit this record